Fny Investment Advisers, LLC Neu Base Therapeutics, Inc. Transaction History

Fny Investment Advisers, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Oct 09, 2020	BUY	$7.25 - $9.71 $108,750 - $145,650	15,000 New	15,000 $113,000
Q2 2020 Jul 10, 2020	SELL	$6.69 - $11.51 $75,396 - $129,717	-11,270 Closed	0 $0
Q1 2020 Apr 09, 2020	BUY	$4.77 - $8.23 $50,600 - $87,303	10,608 Added 1602.42%	11,270 $80,000
Q4 2019 Jan 10, 2020	SELL	$4.5 - $8.1 $74,830 - $134,694	-16,629 Reduced 96.17%	662 $4,000
Q3 2019 Oct 25, 2019	BUY	$3.15 - $6.59 $54,466 - $113,947	17,291 New	17,291 $86,000

Ticker NBSE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 32,258,700
Description
NeuBase Therapeutics, Inc., a pre-clinical-stage biopharmaceutical company, focuses on the development of therapies to treat rare genetic diseases and cancers caused by mutant genes. The company's proprietary modular peptide-nucleic acid antisense oligo (PATrOL) platform focuses on addressing Huntington's disease (HD) and myotonic dystrophy, as ...

Get notified when there are updates to the investment portfolio of Fny Investment Advisers, LLC, based on Form 13F filings with the SEC.

Stay updated on Fny Investment Advisers, LLC with notifications on news.